HomeCDXS • NASDAQ
add
Codexis Inc
Previous close
$1.71
Day range
$1.65 - $1.94
Year range
$0.96 - $3.87
Market cap
149.95M USD
Avg Volume
3.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 38.92M | 81.34% |
Operating expense | 22.91M | 75.56% |
Net income | 9.60M | 192.53% |
Net profit margin | 24.67 | 151.02% |
Earnings per share | 0.14 | 210.00% |
EBITDA | 15.32M | 349.85% |
Effective tax rate | 0.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 78.21M | 6.47% |
Total assets | 147.80M | -0.81% |
Total liabilities | 97.27M | 18.50% |
Total equity | 50.53M | — |
Shares outstanding | 90.40M | — |
Price to book | 3.05 | — |
Return on assets | 25.69% | — |
Return on capital | 30.24% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 9.60M | 192.53% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
188
